These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21476183)

  • 41. Non-Barrett's esophageal and gastric tumors: diagnosis and treatment.
    Ciocirlan M; Gincul R; Lepilliez V; Pioche M; Ionescu ME; Diculescu MM
    Gastrointest Endosc; 2012 Sep; 76(3):501-5. PubMed ID: 22898407
    [No Abstract]   [Full Text] [Related]  

  • 42. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
    Kroese TE; van Rossum PSN; Nilsson M; Lordick F; Smyth EC; Rosati R; Nafteux P; D'Ugo D; Chaudry MA; Polkowkski W; Roviello F; Gockel I; Kolodziejczyk P; Haustermans K; Guckenberger M; Nordsmark M; Hawkins MA; Cervantes A; Fleitas T; van Cutsem E; Moehler M; Wagner AD; van Laarhoven HWM; van Hillegersberg R;
    Eur J Surg Oncol; 2023 Jan; 49(1):21-28. PubMed ID: 36184420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenocarcinoma at the gastroesophageal junction.
    Al-Haddad S; Chang AC; De Hertogh G; Grin A; Langer R; Sagaert X; Salemme M; Streutker CJ; Soucy G; Tripathi M; Upton MP; Vieth M; Villanacci V
    Ann N Y Acad Sci; 2014 Sep; 1325():211-25. PubMed ID: 25266027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Current Status of Immunotherapies in Esophagogastric Cancer.
    Ku GY
    Surg Oncol Clin N Am; 2017 Apr; 26(2):277-292. PubMed ID: 28279469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [What is the esophagogastric junction?].
    Makuuchi H
    Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):24-8. PubMed ID: 25842809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Endoscopic diagnosis and treatment for carcinoma of the esophagogastric junction].
    Goto O; Yahagi N
    Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1776-84. PubMed ID: 26440680
    [No Abstract]   [Full Text] [Related]  

  • 47. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
    J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma.
    Witzig R; Schönberger B; Fink U; Busch R; Gundel H; Sendler A; Peschel C; Siewert JR; Lordick F
    Endoscopy; 2006 Nov; 38(11):1122-6. PubMed ID: 17111334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Benign diseases of the esophagogastric junction: A diagnostic and therapeutic challenge].
    Jähne J
    Chirurg; 2014 Dec; 85(12):1044-5. PubMed ID: 25391997
    [No Abstract]   [Full Text] [Related]  

  • 50. What is adenocarcinoma of the esophagogastric junction?
    Chandrasoma P
    Am J Gastroenterol; 2008 Feb; 103(2):492-3. PubMed ID: 18289219
    [No Abstract]   [Full Text] [Related]  

  • 51. Updates in Esophagogastric Cancer.
    Ilson DH
    Surg Oncol Clin N Am; 2017 Apr; 26(2):xv-xvi. PubMed ID: 28279475
    [No Abstract]   [Full Text] [Related]  

  • 52. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer.
    Hocazade C; Özdemir N; Yazici O; Bozkaya Y; Yazılıtaş D; Toptaş Ş; Zengin N; Deren T
    Ann Nucl Med; 2015 Aug; 29(7):621-6. PubMed ID: 26008856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [II. Treatment Strategy for Esophagogastric Junction Tumor].
    Hashimoto T; Kurokawa Y; Miyazaki Y; Takahashi T; Tanaka K; Makino T; Yamazaki M; Nakajima K; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1248-1253. PubMed ID: 30237365
    [No Abstract]   [Full Text] [Related]  

  • 54. Esophagogastric junction and gastric adenocarcinoma: current challenges and future directions.
    Saba NF
    Oncology (Williston Park); 2014 Jun; 28(6):520-1. PubMed ID: 25134327
    [No Abstract]   [Full Text] [Related]  

  • 55. [S3 guideline - diagnosis and treatment of gastric carcinoma: relevance for radiologic imaging].
    Grenacher L; Schwarz M; Lordick F; Krause B; Roecken C; Moenig S; Ebert M; Jenssen C; Kauczor HU; Moehler M;
    Rofo; 2012 Aug; 184(8):706-12. PubMed ID: 22434371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NCCN practice guidelines for upper gastrointestinal carcinomas. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):179-223. PubMed ID: 10028512
    [No Abstract]   [Full Text] [Related]  

  • 57. The Management of Esophagogastric Cancers Enters a New Era.
    Shah MA
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):xiii-xiv. PubMed ID: 28501094
    [No Abstract]   [Full Text] [Related]  

  • 58. [The concentration of trace elements in cancer patients before and after treatment].
    Nuragdyev SK
    Vopr Onkol; 1971; 17(5):7-12. PubMed ID: 5138547
    [No Abstract]   [Full Text] [Related]  

  • 59. EURECCA oesophago-gastric cancer project.
    Allum W; Osorio J
    Cir Esp; 2016 May; 94(5):255-6. PubMed ID: 26944535
    [No Abstract]   [Full Text] [Related]  

  • 60. Diagnosis of esophagogastric tumors: a trend toward virtual biopsy.
    Lambert R
    Endoscopy; 1999 Jan; 31(1):38-46. PubMed ID: 10082408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.